97 related articles for article (PubMed ID: 27569531)
21. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae.
Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS
Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027
[TBL] [Abstract][Full Text] [Related]
22. Oligonucleotides identify conserved and variable regions of pspA and pspA-like sequences of Streptococcus pneumoniae.
Swiatlo E; Brooks-Walter A; Briles DE; McDaniel LS
Gene; 1997 Apr; 188(2):279-84. PubMed ID: 9133603
[TBL] [Abstract][Full Text] [Related]
23. Unveiling molecular mechanisms of pneumococcal surface protein A interactions with antibodies and lactoferrin.
Jedrzejas MJ
Clin Chim Acta; 2006 May; 367(1-2):1-10. PubMed ID: 16513101
[TBL] [Abstract][Full Text] [Related]
24. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.
Singh R; Singh S; Sharma PK; Singh UP; Briles DE; Hollingshead SK; Lillard JW
PLoS One; 2010 Feb; 5(2):e9432. PubMed ID: 20195541
[TBL] [Abstract][Full Text] [Related]
25. Human apo-lactoferrin enhances angiogenesis mediated by vascular endothelial growth factor A in vivo.
Norrby K
J Vasc Res; 2004; 41(4):293-304. PubMed ID: 15192265
[TBL] [Abstract][Full Text] [Related]
26. Camel lactoferrin, a transferrin-cum-lactoferrin: crystal structure of camel apolactoferrin at 2.6 A resolution and structural basis of its dual role.
Khan JA; Kumar P; Paramasivam M; Yadav RS; Sahani MS; Sharma S; Srinivasan A; Singh TP
J Mol Biol; 2001 Jun; 309(3):751-61. PubMed ID: 11397094
[TBL] [Abstract][Full Text] [Related]
27. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
[TBL] [Abstract][Full Text] [Related]
28. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
Nguyen CT; Kim SY; Kim MS; Lee SE; Rhee JH
Vaccine; 2011 Aug; 29(34):5731-9. PubMed ID: 21696869
[TBL] [Abstract][Full Text] [Related]
29. The genetic background of Streptococcus pneumoniae affects protection in mice immunized with PspA.
He X; McDaniel LS
FEMS Microbiol Lett; 2007 Apr; 269(2):189-95. PubMed ID: 17355599
[TBL] [Abstract][Full Text] [Related]
30. Characterization of Streptococcus pneumoniae isolated from children with otitis media.
Onwubiko C; Shires C; Quin LR; Swiatlo E; McDaniel LS
FEMS Immunol Med Microbiol; 2007 Jun; 50(1):119-25. PubMed ID: 17456178
[TBL] [Abstract][Full Text] [Related]
31. Genetic diversity of PspA types among nasopharyngeal isolates collected during an ongoing surveillance study of children in Brazil.
Pimenta FC; Ribeiro-Dias F; Brandileone MC; Miyaji EN; Leite LC; Sgambatti de Andrade AL
J Clin Microbiol; 2006 Aug; 44(8):2838-43. PubMed ID: 16891500
[TBL] [Abstract][Full Text] [Related]
32. Human antibody responses to pneumococcal surface protein A and capsular polysaccharides during acute and convalescent stages of invasive disease in adult patients.
Kolberg J; Aase A; Naess LM; Aaberge IS; Caugant DA
Pathog Dis; 2014 Feb; 70(1):40-50. PubMed ID: 24151210
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a vaccine formulation against Streptococcus pneumoniae based on choline-binding proteins.
Miyaji EN; Vadesilho CF; Oliveira ML; Zelanis A; Briles DE; Ho PL
Clin Vaccine Immunol; 2015 Feb; 22(2):213-20. PubMed ID: 25520146
[TBL] [Abstract][Full Text] [Related]
34. Contribution of different pneumococcal virulence factors to experimental meningitis in mice.
Ricci S; Gerlini A; Pammolli A; Chiavolini D; Braione V; Tripodi SA; Colombari B; Blasi E; Oggioni MR; Peppoloni S; Pozzi G
BMC Infect Dis; 2013 Sep; 13():444. PubMed ID: 24059458
[TBL] [Abstract][Full Text] [Related]
35. Determination of phenotypes and pneumococcal surface protein A family types of Streptococcus pneumoniae from Malaysian healthy children.
Yatim MM; Masri SN; Desa MN; Taib NM; Nordin SA; Jamal F
J Microbiol Immunol Infect; 2013 Jun; 46(3):180-6. PubMed ID: 22763088
[TBL] [Abstract][Full Text] [Related]
36. Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria.
Nibbering PH; Ravensbergen E; Welling MM; van Berkel LA; van Berkel PH; Pauwels EK; Nuijens JH
Infect Immun; 2001 Mar; 69(3):1469-76. PubMed ID: 11179314
[TBL] [Abstract][Full Text] [Related]
37. A bivalent conjugate vaccine containing PspA families 1 and 2 has the potential to protect against a wide range of Streptococcus pneumoniae strains and Salmonella Typhi.
Kothari N; Kothari S; Choi YJ; Dey A; Briles DE; Rhee DK; Carbis R
Vaccine; 2015 Feb; 33(6):783-8. PubMed ID: 25545593
[TBL] [Abstract][Full Text] [Related]
38. Specific binding of lactoferrin to Escherichia coli isolated from human intestinal infections.
Naidu SS; Erdei J; Czirók E; Kalfas S; Gadó I; Thorén A; Forsgren A; Naidu AS
APMIS; 1991 Dec; 99(12):1142-50. PubMed ID: 1772651
[TBL] [Abstract][Full Text] [Related]
39. Genetic diversity of pneumococcal surface protein A of Streptococcus pneumoniae meningitis in German children.
Heeg C; Franken C; van der Linden M; Al-Lahham A; Reinert RR
Vaccine; 2007 Jan; 25(6):1030-5. PubMed ID: 17084949
[TBL] [Abstract][Full Text] [Related]
40. Human lactoferrin triggers a mitochondrial- and caspase-dependent regulated cell death in Saccharomyces cerevisiae.
Acosta-Zaldívar M; Andrés MT; Rego A; Pereira CS; Fierro JF; Côrte-Real M
Apoptosis; 2016 Feb; 21(2):163-73. PubMed ID: 26577769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
